Health is a sector shaped both by global trends, technologies and innovation, and by local market conditions, demographics and regulations.
Investment and consolidation in Asia are driven by:
- The growth in disposable income, rapidly changing and diversely different demographics;
- Geographically and physiologically distinct characteristics;
- The evolution of government-sponsored health systems; and
- The emergence of true innovators in medical and life science technologies within the region
Access to these growth markets by global participants, and the thirst of regional actors for M&A in both directions between Asia and the West.
Our global Health team serves our corporate, financial sponsor and entrepreneurial clients by combining our deep local capability and insights across Asia with our global perspectives and transactional track record. Our experience spans healthcare services, medical technology, pharma and biotech, outsourced pharma services (CRO, CDMO), consumer health, and animal & plant life sciences.
Senior Managing Director
Divested majority stake to The Longreach Group
Divested plant health business in Japan to Nisso
Divested The Ritedose Corporation to AGIC and Humanwell
Majority recapitalized by Galen Partners
Divested CMC Biologics to Asahi Glass
Acquired Graphic Controls, USA
Divested to a Japanese chemicals & life science company
Sold stake in An Giang Plant Protection to Standard Chartered
Acquired Adval Tech Medical (Suzhou) and Omni Manufacturing (Mexico)
Divested Shanghai Elsker Mother & Baby Co. Ltd to Johnson & Johnson
Divested Radiant Research Inc, US-based clinical research company
Divested medical supply business to Halma in the UK
Established an animal vaccine JV with Jilin Guoyuan Animal Health
Acquired Lablndia distribution business in India
Divested Swine MH vaccine business in China to Harbin Pharmaceutical group